313 related articles for article (PubMed ID: 20091143)
1. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications.
Vidarsson H; Hyllner J; Sartipy P
Stem Cell Rev Rep; 2010 Mar; 6(1):108-20. PubMed ID: 20091143
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
Steel D; Hyllner J; Sartipy P
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
[TBL] [Abstract][Full Text] [Related]
3. Cardiac differentiation of pluripotent stem cells.
Rajala K; Pekkanen-Mattila M; Aalto-Setälä K
Stem Cells Int; 2011; 2011():383709. PubMed ID: 21603143
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Regulation of Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells.
Kim YJ; Tamadon A; Kim YY; Kang BC; Ku SY
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445302
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
Braam SR; Passier R; Mummery CL
Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.
Denning C; Borgdorff V; Crutchley J; Firth KS; George V; Kalra S; Kondrashov A; Hoang MD; Mosqueira D; Patel A; Prodanov L; Rajamohan D; Skarnes WC; Smith JG; Young LE
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1728-48. PubMed ID: 26524115
[TBL] [Abstract][Full Text] [Related]
7. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.
Yang X; Pabon L; Murry CE
Circ Res; 2014 Jan; 114(3):511-23. PubMed ID: 24481842
[TBL] [Abstract][Full Text] [Related]
8. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
Tiburcy M; Hudson JE; Balfanz P; Schlick S; Meyer T; Chang Liao ML; Levent E; Raad F; Zeidler S; Wingender E; Riegler J; Wang M; Gold JD; Kehat I; Wettwer E; Ravens U; Dierickx P; van Laake LW; Goumans MJ; Khadjeh S; Toischer K; Hasenfuss G; Couture LA; Unger A; Linke WA; Araki T; Neel B; Keller G; Gepstein L; Wu JC; Zimmermann WH
Circulation; 2017 May; 135(19):1832-1847. PubMed ID: 28167635
[TBL] [Abstract][Full Text] [Related]
9. Generation, characterization, and potential therapeutic applications of cardiomyocytes from various stem cells.
Liu J; Zhang Z; Liu Y; Guo C; Gong Y; Yang S; Ma M; Li Z; Gao WQ; He Z
Stem Cells Dev; 2012 Aug; 21(12):2095-110. PubMed ID: 22428725
[TBL] [Abstract][Full Text] [Related]
10. Functional cardiomyocytes derived from human induced pluripotent stem cells.
Zhang J; Wilson GF; Soerens AG; Koonce CH; Yu J; Palecek SP; Thomson JA; Kamp TJ
Circ Res; 2009 Feb; 104(4):e30-41. PubMed ID: 19213953
[TBL] [Abstract][Full Text] [Related]
11. Cardiac regeneration using human embryonic stem cells: producing cells for future therapy.
Wong SS; Bernstein HS
Regen Med; 2010 Sep; 5(5):763-75. PubMed ID: 20868331
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cells regulate cardiomyocyte development from embryonic stem cells.
Chen K; Bai H; Arzigian M; Gao YX; Bao J; Wu WS; Shen WF; Wu L; Wang ZZ
J Cell Biochem; 2010 Sep; 111(1):29-39. PubMed ID: 20506197
[TBL] [Abstract][Full Text] [Related]
13. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease.
Zhang F; Pasumarthi KB
BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754
[TBL] [Abstract][Full Text] [Related]
14. In vitro uses of human pluripotent stem cell-derived cardiomyocytes.
Matsa E; Denning C
J Cardiovasc Transl Res; 2012 Oct; 5(5):581-92. PubMed ID: 22639342
[TBL] [Abstract][Full Text] [Related]
15. Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine.
Burridge PW; Sharma A; Wu JC
Annu Rev Genet; 2015; 49():461-84. PubMed ID: 26631515
[TBL] [Abstract][Full Text] [Related]
16. [Review of basic studies about the cardiac stem cell and regenerative medicine].
Tamura Y; Fukuda K
Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview.
Mummery CL; Zhang J; Ng ES; Elliott DA; Elefanty AG; Kamp TJ
Circ Res; 2012 Jul; 111(3):344-58. PubMed ID: 22821908
[TBL] [Abstract][Full Text] [Related]
18. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
Tan SH; Ye L
J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
[TBL] [Abstract][Full Text] [Related]
19. Making cardiomyocytes: how mechanical stimulation can influence differentiation of pluripotent stem cells.
Geuss LR; Suggs LJ
Biotechnol Prog; 2013; 29(5):1089-96. PubMed ID: 23956196
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.
Dick E; Rajamohan D; Ronksley J; Denning C
Biochem Soc Trans; 2010 Aug; 38(4):1037-45. PubMed ID: 20659000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
